@article {1032,
	title = {Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.},
	journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
	volume = {47},
	year = {2008},
	month = {2008 Oct 1},
	pages = {952-61},
	abstract = {More than one-third of people in the United States with hepatic C virus (HCV) infection pass through the correctional system annually. Data are lacking on outcomes of treatment with pegylated interferon plus ribavirin (PEG-RBV) in correctional settings.},
	keywords = {Adult, Antiviral Agents, Drug Therapy, Combination, Female, Hepatitis C, Humans, Interferon-alpha, Longitudinal Studies, Male, Middle Aged, Polyethylene Glycols, Prisoners, Prisons, Recombinant Proteins, Retrospective Studies, Ribavirin},
	issn = {1537-6591},
	doi = {10.1086/591707},
	author = {Maru, Duncan Smith-Rohrberg and Bruce, Robert Douglas and Basu, Sanjay and Altice, Frederick L}
}
